Health Law Alliance (HLA) is proud to share that our very own Diana Yastrovskaya was recently featured for her expertise in a live discussion on Pharmacy Benefit Managers (PBMs) for Pennsylvania TV station, WJAC. In this segment, Diana offered her insights into the complex and often misunderstood role that PBMs play in the healthcare system.
The discussion centered on the impact of PBMs on local pharmacies, the breadth of PBM power, and the challenges this creates for independent businesses. Diana explained how PBMs act as intermediaries between insurers, pharmacies, and drug manufacturers, and how their practices can have significant implications for both patients and providers. She emphasized the importance of transparency in PBM operations and stressed that greater clarity could lead to more affordable and accessible medications for consumers.
Importantly, Diana shared how she works directly with independent pharmacies to help them push back against unfair PBM practices. Through her expertise in healthcare law and regulatory frameworks, she advocates for policies that empower smaller pharmacies to compete on a more level playing field.
Her participation in the WJAC discussion reflects HLA’s ongoing commitment to advancing critical conversations around healthcare law, policy, and practice. By breaking down complex industry dynamics and providing actionable guidance, Diana continues to champion fairness, efficiency, and patient well-being.
Read more about our best PBM Attorney, Diana Yastrovskaya, Esq.
MORE ARTICLES BY CATEGORY
The Performant Audit Playbook: How to Protect Your Practice from New York’s New Medicaid RAC
For years, New York healthcare providers have navigated the complex oversight of the Office of the Medicaid Inspector General (OMIG), primarily through its Medicaid Recovery Audit Contractor (RAC) vendors. In April 2025 the landscape shifted as the state engaged Performant Healthcare Solutions (“Performant”) as its exclusive Medicaid Recovery Audit Contractor (“RAC”).
Read More >>Darmerica - FDA Issues Warning Letter Targeting GLP-1 API Supply Chain Manufacturer
FDA issued a Warning Letter to Darmerica citing cGMP violations and improper distribution of GLP-1 and peptide APIs. Learn what this means for 503A compounding pharmacies and supply chain compliance.
Read More >>Italian Gold Broker Criminally Charged in $86 Million Customs Duty and Tariff Evasion Scheme Released on Bail
Italian national Claudio Fogale was released from federal jail after his attorney, Anthony J. Mahajan, successfully argued that the evidence was weak and legal requirements were ambiguous.
Read More >>PBM Enforcement Trends Independent Pharmacies Must Prepare for in 2026
Independent pharmacies are heading into 2026 under tighter PBM oversight, more aggressive audit practices, and evolving reimbursement models driven by regulatory pressure and DIR fee reform. To survive in this environment, pharmacies must strengthen compliance, documentation, and inventory controls while partnering with experienced PBM counsel to manage audits, protect reimbursements, and avoid network termination.
Read More >>
